Literature DB >> 10584896

Influence of socioeconomic status on features and outcome of community-acquired pneumonia.

S Stelianides1, J L Golmard, C Carbon, B Fantin.   

Abstract

The influence of socioeconomic status on the features and evolution of community-acquired pneumonia in 107 consecutive hospitalized patients was investigated. Thirty-four (31.8%) patients were considered to have a low socioeconomic status. These patients were more likely immigrants, middle-aged, with fewer comorbid illnesses, and were more often tobacco, alcohol, or drug consumers (P<0.01). The distribution of etiologies was significantly different according to socioeconomic status, with tuberculosis occurring more frequently in the low socioeconomic group (P < 0.05). Low socioeconomic status was not associated with a more severe presentation or outcome of pneumonia but was an independent factor that predicted a significantly longer length of hospitalization (5.9 days longer; 95% confidence interval, 2.2-9.5 days; P<0.003), entailing a substantial excess cost per hospital stay.

Entities:  

Mesh:

Year:  1999        PMID: 10584896     DOI: 10.1007/s100960050382

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  9 in total

1.  Factors associated with length of stay in hospital for suspected community-acquired pneumonia.

Authors:  Jane Q Huang; Peter M Hooper; Thomas J Marrie
Journal:  Can Respir J       Date:  2006-09       Impact factor: 2.409

2.  Community-acquired lower respiratory tract infections in HIV-infected patients on antiretroviral therapy: predictors in a contemporary cohort study.

Authors:  Cristiane C Lamas; Lara E Coelho; Beatriz J Grinsztejn; Valdilea G Veloso
Journal:  Infection       Date:  2017-06-28       Impact factor: 3.553

3.  Factors associated with the hospitalization of low-risk patients with community-acquired pneumonia in a cluster-randomized trial.

Authors:  Jose Labarere; Roslyn A Stone; D Scott Obrosky; Donald M Yealy; Thomas P Meehan; Thomas E Auble; Jonathan M Fine; Louis G Graff; Michael J Fine
Journal:  J Gen Intern Med       Date:  2006-07       Impact factor: 5.128

4.  Influence of socioeconomic status on community-acquired pneumonia outcomes in elderly patients requiring hospitalization: a multicenter observational study.

Authors:  Conchita Izquierdo; Manuel Oviedo; Laura Ruiz; Xavier Sintes; Isabel Vera; Manel Nebot; Jose-María Bayas; Jordi Carratalà; Wenceslao Varona; Dolores Sousa; Jose-Miguel Celorrio; Luis Salleras; Angela Domínguez
Journal:  BMC Public Health       Date:  2010-07-15       Impact factor: 3.295

5.  Characteristics and Outcome of Patients With Dual Pulmonary Tuberculosis and Non-mycobacterial Respiratory Infections.

Authors:  Gen-Min Lin; Feng-Yee Chang; Chung-Hsing Chou; Yen-Po Lin; Chih-Hung Ku
Journal:  J Clin Med Res       Date:  2011-11-10

6.  Determinants of short and long term functional recovery after hospitalization for community-acquired pneumonia in the elderly: role of inflammatory markers.

Authors:  Ali El Solh; Lilibeth Pineda; Pam Bouquin; Corey Mankowski
Journal:  BMC Geriatr       Date:  2006-08-09       Impact factor: 3.921

7.  Socioeconomic status and hospital utilization among younger adult pneumonia admissions at a Canadian hospital.

Authors:  Margaret J McGregor; Robert J Reid; Michael Schulzer; J Mark Fitzgerald; Adrian R Levy; Michelle B Cox
Journal:  BMC Health Serv Res       Date:  2006-11-25       Impact factor: 2.655

8.  Does socioeconomic status affect mortality subsequent to hospital admission for community acquired pneumonia among older persons?

Authors:  Linda Vrbova; Muhammad Mamdani; Rahim Moineddin; Liisa Jaakimainen; Ross E G Upshur
Journal:  J Negat Results Biomed       Date:  2005-04-08

9.  Effect of socioeconomic status on mortality after bacteremia in working-age patients. A Danish population-based cohort study.

Authors:  Kristoffer Koch; Mette Nørgaard; Henrik Carl Schønheyder; Reimar Wernich Thomsen; Mette Søgaard
Journal:  PLoS One       Date:  2013-07-25       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.